U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06888362) titled 'Trial to Investigate GZ21T in Healthy Volunteers' on July 15, 2024.
Brief Summary: This is a double-blind, randomised, placebo-controlled trial designed to evaluate safety, tolerability, and pharmacokinetics (PK) after topical administration of single ascending doses of GZ21T in healthy volunteers.
Study Start Date: Aug. 19, 2024
Study Type: INTERVENTIONAL
Condition:
Actinic Keratosis
Intervention:
DRUG: GZ21T
GZ21T cream is intended to be studied as a potential treatment for patients with actinic keratoses and other dermatologic conditions which may be amendable to the study treatment.
Recruitment Status: RECRUITING
Spons...